Insider Holders & Insider Ownership - Nuo Therapeutics Inc. (AURX)

List of insiders holdings for Nuo Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
Aldagen Holdings LLC
Brooke William W
Clark B. Jefferson
May be part of a 13(d) Group
10% Owner
2015-05-13 17:40:4213,139,215
1,109,719
14,248,934Form 4
Aldagen Holdings LLC
Clark B. Jefferson
Brooke William W
Carr Kathryne
May be part of a 13(d) group
10% Owner
2015-03-12 17:36:1613,399,986
0
13,399,986Form 3/A
SHEEDY CHARLES E
10% Owner
2024-09-19 20:21:4511,437,500
3,365
11,440,865Form 4
Boyalife Investment Fund I Inc.
10% Owner
2017-09-21 15:49:136,650,000
0
6,650,000Form 13D
Pittman Scott M.
Director
10% Owner
2024-11-19 17:51:415,396,054
0
5,396,054Form 4
Kent Richard S
Director
2014-01-30 16:08:3560,000
3,477,572
3,537,572Form 4
JORDEN DAVID EMERSON
CEO/CFO
2022-11-14 18:43:281,975,358
0
1,975,358Form 4
MARCUS MICHAEL
10% Owner
2005-09-14 17:30:251,388,500
0
1,388,500Form 13D
Field Edward L.
CHIEF OPERATING OFFICER
2014-06-20 17:33:24834,000
0
834,000Form 4/A
HOHNKE LYLE A
Director
2015-01-06 17:01:07620,000
0
620,000Form 4
CLAUSEN PETER
CSO/COO
2024-05-21 15:13:21586,201
3,474
589,675Form 4
Maslan Andrew Scott
Chief Financial Officer
2012-08-08 16:46:03575,423
0
575,423Form 4
McLoughlin Mark T
Director
2015-01-06 17:02:11435,000
0
435,000Form 4
CREWS DAVID
Director
2009-01-06 14:22:05396,667
0
396,667Form 4
FYLLING CARELYN P
VP of Professional Sevices
2009-09-21 13:51:03384,077
0
384,077Form 4
Benson James
Director
2013-03-20 07:53:13380,000
0
380,000Form 4
KEITH STEPHEN
Director
2015-01-06 17:00:36285,000
0
285,000Form 4
ROSENDALE MARTIN P
Chief Executive Officer
2014-08-21 17:18:07229,149
0
229,149Form 4
Deva Arun K.
Director
2008-09-09 11:22:53220,000
0
220,000Form 4
TOZER DEAN
Chief Commercial Officer
2014-10-08 18:00:32200,000
0
200,000Form 4
CLINE MARK E
President
2004-03-25 19:43:42175,000
0
175,000Form 4
ALLENDER WILLIAM L
Chief Financial Officer
2004-03-25 20:06:42175,000
0
175,000Form 4
DROHAN DAVID F
Director
2008-01-16 17:26:42150,000
0
150,000Form 4
VANEK PATRICK PAUL
VP of Operations
2012-03-19 16:46:18140,000
0
140,000Form 4
MENDELSOHN CRAIG B
Resigned as director 2/9/12
2012-02-13 08:42:0795,000
0
95,000Form 4
SHALLCROSS STEVEN A
Chief Financial Officer
2014-08-27 06:13:0979,500
0
79,500Form 4
Atinsky Lawrence
Director
2019-01-03 16:06:1662,500
0
62,500Form 4
DEL GUERCIO JOSEPH
Director
2017-01-11 20:17:4740,000
0
40,000Form 4
WINZER C ERIC
Director
2024-07-22 18:58:4240,000
0
40,000Form 4
Mintz Paul
Director
2024-07-22 18:50:5325,000
0
25,000Form 4
MOHAN KSHITIJ
Chief Executive Officer
2008-04-03 17:00:3920,000
0
20,000Form 4
BURKETT ROBERT
Director
2005-07-05 16:20:390
0
0Form 4
CYTOMEDIX INC
Director
2004-11-12 17:00:010
0
0Form 3